Company / Income Tax per Share
Charles River Laboratories Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.87
FY2025
5-year range
$0.87 / $1.62
FY2021-FY2025
Trend
-34.4%
vs FY2024
Sector context
#46 of 161
Health Care
What the data says
At $0.87, Charles River Laboratories's income tax per share ranks #116 of 161 in the Health Care sector. Income Tax per Share has declined for 3 consecutive years, from $1.62 in FY2022 to $0.87 in FY2025.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of -4.9%.
Improved from $1.61 to $0.87 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -18.8%
- 5-Year CAGR
- -4.9%
- 10-Year CAGR
- -
Sector benchmark
#116 of 161 in Health CareTop 71% of 161This company $0.87 Sector average $1.03
▼
-15.6% below sector average
Key checks
Key Insights
- Charles River Laboratories's income tax per share has declined for 3 consecutive years.
- In FY2025, income tax per share decreased 34.4% year-over-year.
- Ranks #46 out of 161 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | -34.4% |
| FY2024 | $1.32 | -17.8% |
| FY2023 | $1.61 | -0.8% |
| FY2022 | $1.62 | +61.2% |
| FY2021 | $1.01 | -9.7% |
| FY2020 | $1.11 | -68.7% |
| FY2019 | $3.55 | +209.4% |
| FY2018 | $1.15 | -68.2% |
| FY2017 | $3.62 | +152.8% |
| FY2016 | $1.43 | +105.8% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026